Health Care & Life Sciences » Pharmaceuticals | Sport Endurance Inc.

Sport Endurance Inc. | Income Statement

Fiscal year is September-August. All values USD Thousands.
2013
2014
2015
2016
2017
Sales/Revenue
-
-
-
0.00
1.70
Cost of Goods Sold (COGS) incl. D&A
4.20
4.20
2.20
2.20
0.30
Gross Income
4.20
4.20
2.20
2.10
1.40
SG&A Expense
17.90
23.10
22.50
208.60
525.40
EBIT
22.10
27.30
24.70
210.70
524.00
Unusual Expense
-
-
-
311.10
388.50
Interest Expense
72.10
24.00
25.00
412.00
830.70
Pretax Income
94.20
51.20
49.70
933.80
1,743.30
Consolidated Net Income
94.20
51.20
49.70
933.80
1,743.30
Net Income
94.20
51.20
49.70
933.80
1,743.30
Net Income After Extraordinaries
94.20
51.20
49.70
933.80
1,743.30
Net Income Available to Common
94.20
51.20
49.70
933.80
1,743.30
EPS (Basic)
1.56
0.00
0.00
0.01
0.02
Basic Shares Outstanding
60.40
27,772.00
37,581.90
70,463.30
77,918.70
EPS (Diluted)
1.56
0.00
0.00
0.01
0.02
Diluted Shares Outstanding
60.40
27,772.00
37,581.90
70,463.30
77,918.70
EBITDA
17.90
23.10
22.50
208.50
524.00

About Sport Endurance

View Profile
Address
222 Broadway
New York New York 10038
United States
Employees -
Website http://www.sportenduranceinc.com
Updated 09/14/2018
Sport Endurance, Inc. engages in the development, manufacture, and distribution of dietary supplements products in the areas of total wellness, performance, and recovery. Its products include Ultra Peak T, Sports Leg & Lung Formula, and Pain-Freeze Recovery Gel. The company was founded on January 3, 2001 and is headquartered in New York, NY.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.